To study CLL/CAR T-cell interactions, second-generation CD19- and ROR1-directed CAR T cells with a 4-1BB intracellular signaling domain (Fig. 1A) were serially stimulated with primary CLL cells every 5 days for three total stimulations (Fig. 1B). The gene discussed is ROR1; the disease is B-cell chronic lymphocytic leukemia.